| A case of Etanercept-associated malignant lymphoma in a patient with rheumatoid arthritis |
|
Sang Kyung Jung, Ju Hyun Lee, June Sung Lee, Hye Ran Lee, Sun Hee Chang, Bo Young Yoon |
|
|
| Etanercept으로 치료한 류마티스관절염 환자에서 발생한 악성 림프종 1예 |
|
정상경·이주현·이준성·이혜란·장선희·윤보영, Ju Hyun Lee, June Sung Lee, Hye Ran Lee, Sun Hee Chang, Bo Young Yoon |
|
|
|
|
|
|
| Abstract |
|
Rheumatoid arthritis (RA) is a chronic inflammatory polyarthritis that is associated with an increased risk of coronary artery disease,
infection, lymphoma, and life expectancy. Several studies have shown that patients with RA have a 2~3x increased risk of developing
lymphomas as compared with the general population. TNF-α antagonist therapy might be independently associated with
an increased risk of lymphoma; however, other studies have shown that the risk of lymphoma is increased in RA patients with severe
disease activity rather than the treatment per se. We experienced a 65-year-old woman who developed Etanercept–associated
malignant lymphoma with rheumatoid arthritis. (Korean J Med 77:S1342-S1346, 2009) |
| Key Words:
Etanercept; Malignant lymphoma; Rheumatoid arthritis |
|
PDF Links
Full text via DOI
Download Citation
